Abiraterone Acetate In Patients With Metastatic Castration-Resistant Prostate Cancer, Chemo-Naive, Who Received A Prior Diethylstilbestrol Therapy.
JOURNAL OF CLINICAL ONCOLOGY(2021)
摘要
130Background: The use of diethylstilbestrol (DES) for the treatment of metastatic castration resistant prostate cancer (mCRPC) is very common in developing countries. Retrospective data suggests t...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要